FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280549033> ?p ?o ?g. }

• W4280549033 endingPage "156" @default.
• W4280549033 startingPage "147" @default.
• W4280549033 abstract "Objective Sarcopenia and sarcopenic obesity (SO) are linked to unfavorable prognosis in maintenance hemodialysis (MHD) populations. We tested whether nonobese sarcopenia and SO, as different stages of extreme protein-energy wasting, have different prognoses. Methods In this prospective observational study, 261 MHD patients were recruited from October 2010 to April 2012 and followed until October 2020. Two definitions were used to diagnose sarcopenia: the European Working Group on Sarcopenia in Older People consensus and the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium criteria. Obesity was determined as the percentage of total body fat, ≥27% for men and ≥38% for women. Data for all-cause and cardiovascular morbidity and mortality, baseline nutrition markers, inflammation and oxidative stress, adipokines, body composition parameters, handgrip strength, and quality of life (QoL) scores were measured. Results According to European Working Group on Sarcopenia in Older People, 115 (44.1%) patients were sarcopenic and 120 (46.0%) according to FNIH definitions. Of them, 28.4% and 34.5% were SO, respectively. Higher levels of albumin, creatinine, uric acid, leptin, phase angle, better nutritional scores, and lower adiponectin levels characterized SO patients compared with nonobese sarcopenic patients regardless of indexing method. Better QoL scores were noted in SO compared with nonobese sarcopenic patients using the FNIH sarcopenia criteria. The hazard of all-cause death, cardiovascular death, and first cardiovascular event for patients with SO was lower compared with the nonobese patients after multivariate adjustments. Statistical significance of these associations disappeared after including fat mass in multivariate models. Conclusions MHD patients with SO have better nutritional status and prognosis for cardiovascular events, all-cause and cardiovascular disease mortality, and possibly better QoL compared with nonobese sarcopenic MHD patients. The better prognosis appears to be entirely due to the excess fat, which is protective in sarcopenic MHD patients similar to that described in the entire MHD population. Sarcopenia and sarcopenic obesity (SO) are linked to unfavorable prognosis in maintenance hemodialysis (MHD) populations. We tested whether nonobese sarcopenia and SO, as different stages of extreme protein-energy wasting, have different prognoses. In this prospective observational study, 261 MHD patients were recruited from October 2010 to April 2012 and followed until October 2020. Two definitions were used to diagnose sarcopenia: the European Working Group on Sarcopenia in Older People consensus and the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium criteria. Obesity was determined as the percentage of total body fat, ≥27% for men and ≥38% for women. Data for all-cause and cardiovascular morbidity and mortality, baseline nutrition markers, inflammation and oxidative stress, adipokines, body composition parameters, handgrip strength, and quality of life (QoL) scores were measured. According to European Working Group on Sarcopenia in Older People, 115 (44.1%) patients were sarcopenic and 120 (46.0%) according to FNIH definitions. Of them, 28.4% and 34.5% were SO, respectively. Higher levels of albumin, creatinine, uric acid, leptin, phase angle, better nutritional scores, and lower adiponectin levels characterized SO patients compared with nonobese sarcopenic patients regardless of indexing method. Better QoL scores were noted in SO compared with nonobese sarcopenic patients using the FNIH sarcopenia criteria. The hazard of all-cause death, cardiovascular death, and first cardiovascular event for patients with SO was lower compared with the nonobese patients after multivariate adjustments. Statistical significance of these associations disappeared after including fat mass in multivariate models. MHD patients with SO have better nutritional status and prognosis for cardiovascular events, all-cause and cardiovascular disease mortality, and possibly better QoL compared with nonobese sarcopenic MHD patients. The better prognosis appears to be entirely due to the excess fat, which is protective in sarcopenic MHD patients similar to that described in the entire MHD population." @default.
• W4280549033 created "2022-05-22" @default.
• W4280549033 creator A5009821887 @default.
• W4280549033 creator A5013868157 @default.
• W4280549033 creator A5038902460 @default.
• W4280549033 creator A5042766986 @default.
• W4280549033 creator A5053050561 @default.
• W4280549033 creator A5064149734 @default.
• W4280549033 creator A5064760705 @default.
• W4280549033 date "2023-01-01" @default.
• W4280549033 modified "2023-10-09" @default.
• W4280549033 title "Sarcopenic Obesity Versus Nonobese Sarcopenia in Hemodialysis Patients: Differences in Nutritional Status, Quality of Life, and Clinical Outcomes" @default.
• W4280549033 cites W1582716167 @default.
• W4280549033 cites W1910718411 @default.
• W4280549033 cites W1973127865 @default.
• W4280549033 cites W1973808426 @default.
• W4280549033 cites W1976716862 @default.
• W4280549033 cites W1985893641 @default.
• W4280549033 cites W2002377266 @default.
• W4280549033 cites W2018384297 @default.
• W4280549033 cites W2024543272 @default.
• W4280549033 cites W2034361573 @default.
• W4280549033 cites W2050540953 @default.
• W4280549033 cites W2063296159 @default.
• W4280549033 cites W2081600698 @default.
• W4280549033 cites W2089248751 @default.
• W4280549033 cites W2097768141 @default.
• W4280549033 cites W2097772356 @default.
• W4280549033 cites W2100683179 @default.
• W4280549033 cites W2102902846 @default.
• W4280549033 cites W2108349450 @default.
• W4280549033 cites W2111253761 @default.
• W4280549033 cites W2138741207 @default.
• W4280549033 cites W2147055256 @default.
• W4280549033 cites W2149295929 @default.
• W4280549033 cites W2150186338 @default.
• W4280549033 cites W2151420177 @default.
• W4280549033 cites W2155832387 @default.
• W4280549033 cites W2156791190 @default.
• W4280549033 cites W2157300817 @default.
• W4280549033 cites W2227033802 @default.
• W4280549033 cites W2336309365 @default.
• W4280549033 cites W2396779477 @default.
• W4280549033 cites W2511219518 @default.
• W4280549033 cites W2547657060 @default.
• W4280549033 cites W2551531911 @default.
• W4280549033 cites W2596804147 @default.
• W4280549033 cites W2769725033 @default.
• W4280549033 cites W2796001223 @default.
• W4280549033 cites W2801971194 @default.
• W4280549033 cites W2885364038 @default.
• W4280549033 cites W2895377702 @default.
• W4280549033 cites W2897513125 @default.
• W4280549033 cites W2897608848 @default.
• W4280549033 cites W2901294932 @default.
• W4280549033 cites W2989188582 @default.
• W4280549033 cites W2991498934 @default.
• W4280549033 cites W2995343586 @default.
• W4280549033 cites W3113000524 @default.
• W4280549033 doi "https://doi.org/10.1053/j.jrn.2022.05.003" @default.
• W4280549033 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35597322" @default.
• W4280549033 hasPublicationYear "2023" @default.
• W4280549033 type Work @default.
• W4280549033 citedByCount "9" @default.
• W4280549033 countsByYear W42805490332023 @default.
• W4280549033 crossrefType "journal-article" @default.
• W4280549033 hasAuthorship W4280549033A5009821887 @default.
• W4280549033 hasAuthorship W4280549033A5013868157 @default.
• W4280549033 hasAuthorship W4280549033A5038902460 @default.
• W4280549033 hasAuthorship W4280549033A5042766986 @default.
• W4280549033 hasAuthorship W4280549033A5053050561 @default.
• W4280549033 hasAuthorship W4280549033A5064149734 @default.
• W4280549033 hasAuthorship W4280549033A5064760705 @default.
• W4280549033 hasConcept C126322002 @default.
• W4280549033 hasConcept C159110408 @default.
• W4280549033 hasConcept C1862650 @default.
• W4280549033 hasConcept C194832188 @default.
• W4280549033 hasConcept C2776214593 @default.
• W4280549033 hasConcept C2776782570 @default.
• W4280549033 hasConcept C2777328239 @default.
• W4280549033 hasConcept C2777391703 @default.
• W4280549033 hasConcept C2778063415 @default.
• W4280549033 hasConcept C2779951463 @default.
• W4280549033 hasConcept C2780221984 @default.
• W4280549033 hasConcept C2780613262 @default.
• W4280549033 hasConcept C511355011 @default.
• W4280549033 hasConcept C71924100 @default.
• W4280549033 hasConcept C74909509 @default.
• W4280549033 hasConceptScore W4280549033C126322002 @default.
• W4280549033 hasConceptScore W4280549033C159110408 @default.
• W4280549033 hasConceptScore W4280549033C1862650 @default.
• W4280549033 hasConceptScore W4280549033C194832188 @default.
• W4280549033 hasConceptScore W4280549033C2776214593 @default.
• W4280549033 hasConceptScore W4280549033C2776782570 @default.
• W4280549033 hasConceptScore W4280549033C2777328239 @default.
• W4280549033 hasConceptScore W4280549033C2777391703 @default.
• W4280549033 hasConceptScore W4280549033C2778063415 @default.
• W4280549033 hasConceptScore W4280549033C2779951463 @default.

• next